Guangdong Biolight Meditech Co., Ltd. (300246.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.14B
Enterprise Value2.27B
P/E Ratio-30.39
PEG Ratio0.6
Price/Sales Ratio3.18
Price/Book Ratio3.24
Enterprise/Revenue3.21
Enterprise/EBITDA-79.17

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.1
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.11

Income Statement

Revenue1.1B
Revenue/Share4.27
Gross Profit281.53M
EBITDA27.35M
Net Income-69.43M
Diluted EPS-0.26

Balance Sheet

Total Cash388.72M
Total Cash/Share1.49
Total Debt397.43M
Total Debt/Equity0.37
Current Ratio1.5
Book Value Per Share4.42

Price History

52-Week Change48.18
52-Week High21.98
52-Week Low7.67
Moving Average 50 Days14.16
Moving Average 200 Days15.57

Statistics

Average Volume8.5M
Shares Outstanding264.76M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.37
Payout Ratio-0.51
Last Split Factor3:2
Last Split DateMay 25, 2023
AD